Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice

Anantha Vijay R Santhanam, Livius V. D'Uscio, Tongrong He, Pritam Das, Steven G Younkin, Zvonimir S Katusic

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In this study, we tested the hypothesis that reduced bioavailability of tetrahydrobiopterin (BH<inf>4</inf>) is a major mechanism responsible for pathogenesis of endothelial dysfunction in cerebral microvessels of transgenic mice expressing the Swedish double mutation of human amyloid precursor protein (APP) (Tg2576 mice). Endothelial nitric oxide synthase (eNOS) protein expression was significantly increased in cerebral vasculature of Tg2576 mice. In contrast, bioavailability of BH<inf>4</inf> was significantly reduced (p < 0.05). Moreover, superoxide anion production was increased in cerebral microvessels of Tg2576 mice (p < 0.05). Incubation with NOS inhibitor, N<sup>ω</sup>-nitro-L-arginine methyl ester, decreased superoxide anion indicating that uncoupled eNOS is most likely the source of superoxide anion. Increasing BH<inf>4</inf> bioavailability either exogenously by BH<inf>4</inf> supplementation or endogenously by treatment with the selective peroxisome proliferator-activated receptor - delta activator GW501516 (2 mg/kg/day, 14 days) attenuated eNOS uncoupling and decreased superoxide anion production in cerebral microvessels of Tg2576 mice (p < 0.05). Treatment with GW501516 restored the biological activity of endothelial nitric oxide in cerebral microvessels of Tg2576 mice, as indicated by the increased nitrite/nitrate content and 3,5-cyclic guanosine monophosphate levels (p < 0.05). Our studies indicate that sub-optimal BH<inf>4</inf> bioavailability in cerebral vasculature is an important contributor to oxidant stress and endothelial dysfunction in Tg2576 mouse model of Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)1129-1138
Number of pages10
JournalJournal of Neurochemistry
Volume134
Issue number6
DOIs
StatePublished - Sep 1 2015

Fingerprint

Nitric Oxide Synthase Type III
Biological Availability
Superoxides
Microvessels
PPAR delta
Amyloid beta-Protein Precursor
Oxidants
Transgenic Mice
Alzheimer Disease
Mutation
Proteins

Keywords

  • Alzheimer's disease
  • endothelial dysfunction
  • oxidative stress
  • superoxide anions
  • tetrahydrobiopterin

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice. / Santhanam, Anantha Vijay R; D'Uscio, Livius V.; He, Tongrong; Das, Pritam; Younkin, Steven G; Katusic, Zvonimir S.

In: Journal of Neurochemistry, Vol. 134, No. 6, 01.09.2015, p. 1129-1138.

Research output: Contribution to journalArticle

Santhanam, Anantha Vijay R ; D'Uscio, Livius V. ; He, Tongrong ; Das, Pritam ; Younkin, Steven G ; Katusic, Zvonimir S. / Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice. In: Journal of Neurochemistry. 2015 ; Vol. 134, No. 6. pp. 1129-1138.
@article{ead5d32312654b558cac437d1f9c140d,
title = "Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice",
abstract = "In this study, we tested the hypothesis that reduced bioavailability of tetrahydrobiopterin (BH4) is a major mechanism responsible for pathogenesis of endothelial dysfunction in cerebral microvessels of transgenic mice expressing the Swedish double mutation of human amyloid precursor protein (APP) (Tg2576 mice). Endothelial nitric oxide synthase (eNOS) protein expression was significantly increased in cerebral vasculature of Tg2576 mice. In contrast, bioavailability of BH4 was significantly reduced (p < 0.05). Moreover, superoxide anion production was increased in cerebral microvessels of Tg2576 mice (p < 0.05). Incubation with NOS inhibitor, Nω-nitro-L-arginine methyl ester, decreased superoxide anion indicating that uncoupled eNOS is most likely the source of superoxide anion. Increasing BH4 bioavailability either exogenously by BH4 supplementation or endogenously by treatment with the selective peroxisome proliferator-activated receptor - delta activator GW501516 (2 mg/kg/day, 14 days) attenuated eNOS uncoupling and decreased superoxide anion production in cerebral microvessels of Tg2576 mice (p < 0.05). Treatment with GW501516 restored the biological activity of endothelial nitric oxide in cerebral microvessels of Tg2576 mice, as indicated by the increased nitrite/nitrate content and 3,5-cyclic guanosine monophosphate levels (p < 0.05). Our studies indicate that sub-optimal BH4 bioavailability in cerebral vasculature is an important contributor to oxidant stress and endothelial dysfunction in Tg2576 mouse model of Alzheimer's disease.",
keywords = "Alzheimer's disease, endothelial dysfunction, oxidative stress, superoxide anions, tetrahydrobiopterin",
author = "Santhanam, {Anantha Vijay R} and D'Uscio, {Livius V.} and Tongrong He and Pritam Das and Younkin, {Steven G} and Katusic, {Zvonimir S}",
year = "2015",
month = "9",
day = "1",
doi = "10.1111/jnc.13205",
language = "English (US)",
volume = "134",
pages = "1129--1138",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice

AU - Santhanam, Anantha Vijay R

AU - D'Uscio, Livius V.

AU - He, Tongrong

AU - Das, Pritam

AU - Younkin, Steven G

AU - Katusic, Zvonimir S

PY - 2015/9/1

Y1 - 2015/9/1

N2 - In this study, we tested the hypothesis that reduced bioavailability of tetrahydrobiopterin (BH4) is a major mechanism responsible for pathogenesis of endothelial dysfunction in cerebral microvessels of transgenic mice expressing the Swedish double mutation of human amyloid precursor protein (APP) (Tg2576 mice). Endothelial nitric oxide synthase (eNOS) protein expression was significantly increased in cerebral vasculature of Tg2576 mice. In contrast, bioavailability of BH4 was significantly reduced (p < 0.05). Moreover, superoxide anion production was increased in cerebral microvessels of Tg2576 mice (p < 0.05). Incubation with NOS inhibitor, Nω-nitro-L-arginine methyl ester, decreased superoxide anion indicating that uncoupled eNOS is most likely the source of superoxide anion. Increasing BH4 bioavailability either exogenously by BH4 supplementation or endogenously by treatment with the selective peroxisome proliferator-activated receptor - delta activator GW501516 (2 mg/kg/day, 14 days) attenuated eNOS uncoupling and decreased superoxide anion production in cerebral microvessels of Tg2576 mice (p < 0.05). Treatment with GW501516 restored the biological activity of endothelial nitric oxide in cerebral microvessels of Tg2576 mice, as indicated by the increased nitrite/nitrate content and 3,5-cyclic guanosine monophosphate levels (p < 0.05). Our studies indicate that sub-optimal BH4 bioavailability in cerebral vasculature is an important contributor to oxidant stress and endothelial dysfunction in Tg2576 mouse model of Alzheimer's disease.

AB - In this study, we tested the hypothesis that reduced bioavailability of tetrahydrobiopterin (BH4) is a major mechanism responsible for pathogenesis of endothelial dysfunction in cerebral microvessels of transgenic mice expressing the Swedish double mutation of human amyloid precursor protein (APP) (Tg2576 mice). Endothelial nitric oxide synthase (eNOS) protein expression was significantly increased in cerebral vasculature of Tg2576 mice. In contrast, bioavailability of BH4 was significantly reduced (p < 0.05). Moreover, superoxide anion production was increased in cerebral microvessels of Tg2576 mice (p < 0.05). Incubation with NOS inhibitor, Nω-nitro-L-arginine methyl ester, decreased superoxide anion indicating that uncoupled eNOS is most likely the source of superoxide anion. Increasing BH4 bioavailability either exogenously by BH4 supplementation or endogenously by treatment with the selective peroxisome proliferator-activated receptor - delta activator GW501516 (2 mg/kg/day, 14 days) attenuated eNOS uncoupling and decreased superoxide anion production in cerebral microvessels of Tg2576 mice (p < 0.05). Treatment with GW501516 restored the biological activity of endothelial nitric oxide in cerebral microvessels of Tg2576 mice, as indicated by the increased nitrite/nitrate content and 3,5-cyclic guanosine monophosphate levels (p < 0.05). Our studies indicate that sub-optimal BH4 bioavailability in cerebral vasculature is an important contributor to oxidant stress and endothelial dysfunction in Tg2576 mouse model of Alzheimer's disease.

KW - Alzheimer's disease

KW - endothelial dysfunction

KW - oxidative stress

KW - superoxide anions

KW - tetrahydrobiopterin

UR - http://www.scopus.com/inward/record.url?scp=84941710668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941710668&partnerID=8YFLogxK

U2 - 10.1111/jnc.13205

DO - 10.1111/jnc.13205

M3 - Article

C2 - 26111938

AN - SCOPUS:84941710668

VL - 134

SP - 1129

EP - 1138

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -